Sabra Healthcare REITSBRA
Recorded

Sabra Healthcare REIT 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration46 minParticipants15

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good day, everyone. My name is Piercy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Health Care REIT Third Quarter 2026 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number 1 on your telephone keypad. If you would like to withdraw your question, press star one again. I would now like to turn the call over to Lukas Hartwich, EVP Finance. Please go ahead, Mr. Hartwich.

Lukas HartwichEVP of Finance

Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026, and our expectations regarding our tenants and operators, and our expectations regarding our acquisition, disposition, and investment plans. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2025, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday.

Lukas HartwichEVP of Finance

We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid. In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures, as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the financials page of the investor section of our website at sabrahealth.com. Our Form 10-Q, earnings release, and supplement can also be accessed in the investor section of our website. With that, let me turn the call over to Rick Matros, CEO, President, and Chair of Sabra Health Care REIT.

Rick MatrosCEO, President, and Chair of the Board

Thanks, Lukas, and thanks, everybody, for joining us this morning. Our same-store SHOP cash NOI margins to 34.9%, which is best in class. Our RevPOR growth was stellar again for the quarter, along with solid cash NOI growth and occupancy increases. We have closed on $750 million in investments to date, all of which is SHOP except for $100 million, which was skilled nursing. We have $425 million awarded and expect more to come before year-end. All of that but $24 million is SHOP. Our skilled nursing and senior housing triple-net rent coverage continues to get better. As we continue to move forward towards 40% SHOP exposure, going to 50% by year-end 2027, our senior housing portfolio will outweigh our skilled portfolio for the first time as that exposure drifts closer to 40%. We see no barriers that would prevent this momentum from continuing.

Rick MatrosCEO, President, and Chair of the Board

That said, we believe it is important to have that diversity in the portfolio. As we have demonstrated, our skilled portfolio offers more earnings growth than the 2.5% escalators that we have seen historically. Our focus on optimizing rents was evident in our July announcement, and we are currently assessing other opportunities. Additionally, as you look to our lease expirations, we expect to see rent increases in those portfolios as rents get reset to fair market, given how much higher than fair market rent coverages currently are. The strategic focus that we have had will result in 7%-8% year-over-year earnings growth at the midpoint of guidance this year, certainly a mark we feel good about and bodes well for that portfolio's contribution to future earnings. With that, I will turn it over to Derek.

Darrin SmithChief Investment Officer

Thank you, Rick. Sabra's senior housing operating portfolio had another great quarter with continued growth. The total senior housing operating portfolio, including non-stabilized communities and joint venture assets that share, had sequential revenue growth of 10.3% and NOI growth of 8.5%. These statistics demonstrate sequential improvement in operating results that reflect our SHOP's continued growth and strong performance. During the third quarter, Sabra invested $222.8 million, adding seven SHOP communities to Sabra's portfolio. Subsequent to quarter end, Sabra invested an additional $140.7 million, adding four SHOP communities, bringing total year-to-date investments to over $747 million with an estimated yield of 8%. Additionally, Sabra has another $425 million of additional awarded investments, nearly all SHOP, which should close in the near future.

Darrin SmithChief Investment Officer

In addition to the over $1.17 billion in closed and awarded investments, Sabra has an additional $260 million of SHOP investments that we are actively pursuing. On a year-over-year basis, Sabra added 18 SHOP communities, an 18% increase by number of assets, and over 60% increase in total SHOP NOI. Deal flow shows no signs of slowing, and Sabra remains competitive on new investments. Moving on to the same-store portfolio. Sabra's same-store SHOP portfolio, including joint venture assets that share, continued its strong performance in the third quarter. The key numbers are: revenue for the quarter grew 9.3% year-over-year, with our Canadian communities growing revenue by 7% in the same period. Third-quarter occupancy in our same-store portfolio was up 160 basis points to 89.2% year-over-year.

Darrin SmithChief Investment Officer

Notably, our domestic portfolio occupancy increased 211 basis points to 86.9% during that period, while our Canadian portfolio grew 77 basis points to 93.9% in the same period, marking the 10th consecutive quarter where occupancy was over 90%. Rent for the third quarter continued to rise with an increase of 7.3% year-over-year, with our Canadian portfolio increasing 6.2% in the same period. While RevPOR and occupancy continue to grow, ExPOR increased 4.7% for the same period, providing for cash NOI growth of 14.6% on a year-over-year basis. The increase in ExPOR was driven primarily by repairs and maintenance, sales and marketing, and incentive management fees, while labor continues to grow less than 3%. With over $1.17 billion in closed and award investments to date, a very robust pipeline, and industry tailwinds at our backs, we should continue to see solid growth in our portfolio.

Darrin SmithChief Investment Officer

With that, I will turn the call over to Michael Costa, Sabra's Chief Financial Officer.

Michael CostaCFO

Thanks, Darrin. For the third quarter of 2026, we recognized normalized FFO per share of $0.39 and normalized AFFO per share of $0.41, compared to $0.38 and $0.40 respectively in the second quarter. Year-over-year, our third quarter normalized FFO per share and normalized AFFO per share each posted an increase of 8%. Cash rental income from our triple-net portfolio increased $1.2 million on a normalized basis compared to the second quarter. Cash rental income was $93.5 million for the quarter, excluding a $10.2 million payment of deferred rents received in the quarter. On a normalized basis, our second quarter cash rental income was $92.3 million after adjusting for $1.8 million of out-of-period revenues, primarily related to the Avamere rent reset. SHOP cash NOI was $48.4 million this quarter compared to $44.6 million last quarter.

Michael CostaCFO

This increase reflects both the contribution from recent investment activity, including seven communities added during the quarter, and continued same-store occupancy gains and rate growth. Interest and other income was $3.2 million for the quarter compared to $5.8 million in the second quarter. The decrease was primarily due to repayments of loans in the second and third quarters. Cash interest expense was $26.8 million for the quarter compared to $27.4 million in the second quarter. The decrease reflects lower borrowings under our credit facility during the period. Normalized cash G&A was $10.6 million for the quarter compared to $10.7 million last quarter. During the quarter, we wrote off $6.2 million of straight-line rent receivables and lease intangibles, primarily due to the transitioning of the former Avamere portfolio. This amount was normalized in our quarterly results.

Michael CostaCFO

We have updated our 2026 earnings guidance and increased the midpoint of our per-share normalized FFO and normalized AFFO by half a penny. At the midpoint, this represents year-over-year per-share growth of 7% for normalized FFO and 8% for normalized AFFO. Now briefly turning to the balance sheet. Our net debt to adjusted EBITDA ratio was 4.54 times as of September 30, 2026, compared to 4.61 times at June 30, 2026. As we have stated previously, our strategy is to naturally lower our leverage over time without sacrificing earnings growth. This quarter's results reflect that strategy in action, and it is a strategy we will continue to employ. As of September 30, 2026, we had approximately $1.2 billion of liquidity and were in compliance with all of our debt covenants.

Michael CostaCFO

In addition to $36.2 million of unrestricted cash and cash equivalents and $873.5 million of available borrowings under our revolving credit facility, we had $292.5 million related to shares outstanding under forward sales agreement under our ATM program, which consisted of 15 million shares at an initial weighted average price of $19.53 per share, net of commissions. Additionally, we have $332.7 million of availability remaining under the ATM program. During the quarter, we issued 6.5 million shares in settlement of certain outstanding forward sales agreements under our ATM program at a weighted average price of $17.89 per share, net of commissions, resulting in net proceeds of $116.2 million. These proceeds, together with cash on hand, were used to fund our investment activity during the quarter.

Michael CostaCFO

Finally, on November 2, 2026, Sabra's board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on November 30, 2026, to common stockholders of record as of the close of business on November 13, 2026. The dividend is well covered and represents a payout of 73% of our third quarter normalized AFFO per share. With that, we'll open up the lines for Q&A.

Operator

We will now begin the question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Juan Sanabria with BMO Capital Markets. Your line is now open.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day